Nuvation Bio Inc - Ordinary Shares - Class A

NYSE:NUVB  
9.69
-0.31 (-3.10%)
Earnings Announcements

Nuvation Bio Reports Second Quarter 2021 Financial Results And Provides Business Update

Published: 08/12/2021 22:17 GMT
Nuvation Bio Inc - Ordinary Shares - Class A (NUVB) - Nuvation Bio Reports Second Quarter 2021 Financial Results and Provides Business Update.
Q2 Loss per Share $0.09.
Q2 Earnings per Share Estimate $-0.10 -- Refinitiv Ibes Data (analyst estimates).
Qtrly Loss per Share $0.09.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.11

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.12

More details on our Analysts Page.